Taltz ® (ixekizumab) injektion

För fullständig produktresumé för Taltz® se FASS.

Denna information är endast avsedd för sjukvårdspersonal verksam i Sverige och som svar på din fråga. Informationen nedan är på engelska

Taltz® ▼ (ixekizumab): Vad är dosregimen vid axial spondyloartrit?

Den rekommenderade dosen är 160 mg subkutan injektion (två 80mg injektioner) vecka 0, sedan 80 mg var 4:e vecka.

Administration Instructions 

Ixekizumab is intended for use under the guidance and supervision of a physician experienced in the diagnosis and treatment of conditions for which Ixekizumab is indicated.1

Ixekizumab is for subcutaneous injection. Injection sites may be alternated. If possible, areas of the skin that show psoriasis should be avoided as injection sites. The solution/the syringe must not be shaken.1

Each ixekizumab injection is to be administered

  • at a different anatomic location (such as upper arms, thighs, or any quadrant of the abdomen) than the previous injection, and

  • not into areas where the skin is tender, bruised, erythematous, indurated, or affected by psoriasis.2

Administration into the upper outer arm may be performed by a caregiver or healthcare provider.2

After proper training in subcutaneous injection technique, patients may self-inject ixekizumab if a healthcare professional determines that it is appropriate. However, the physician should ensure appropriate follow-up of patients. Comprehensive instructions for administration are given in the package leaflet and the user manual.1

Device options

There are 2 presentations for ixekizumab.

  • Ixekizumab 80 mg/ml solution is contained in a single-dose prefilled pen.

  • Ixekizumab 80 mg/ml solution is contained in a single-dose prefilled syringe.1

References

1. Taltz [summary of product characteristics]. Eli Lilly Nederland B.V., The Netherlands.

2. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Datum fӧr senaste ӧversyn 2020 M06 17


Kontakta Medicinsk Information på Lilly

Kontakta oss på telefon

Kontorstid vardagar 9.00-17.00

Eller så kan du

Skriv din fråga till oss